Crysvita Evrópusambandið - íslenska - EMA (European Medicines Agency)

crysvita

kyowa kirin holdings b.v. - burosumab - hypophosphatemia, familial; hypophosphatemic rickets, x-linked dominant; osteomalacia - lyf til að meðhöndla beinsjúkdóma - crysvita is indicated for the treatment of x-linked hypophosphataemia, in children and adolescents aged 1 to 17 years with radiographic evidence of bone disease, and in adults. crysvita is indicated for the treatment of fgf23-related hypophosphataemia in tumour-induced osteomalacia associated with phosphaturic mesenchymal tumours that cannot be curatively resected or localised in children and adolescents aged 1 to 17 years and in adults.

Amvuttra Evrópusambandið - íslenska - EMA (European Medicines Agency)

amvuttra

alnylam netherlands b.v. - vutrisiran sodium - amyloid neuropathies, familial - Önnur lyf í taugakerfinu - treatment of hereditary transthyretin-mediated amyloidosis (hattr amyloidosis) in adult patients with stage 1 or stage 2 polyneuropathy.

Colchicine Tiofarma Tafla 0,5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

colchicine tiofarma tafla 0,5 mg

tiofarma b.v. - colchicinum - tafla - 0,5 mg

Colrefuz Tafla 500 míkróg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

colrefuz tafla 500 míkróg

teva b.v.* - colchicinum - tafla - 500 míkróg

Kaliumklorid B. Braun Innrennslisþykkni, lausn 1 mmol/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

kaliumklorid b. braun innrennslisþykkni, lausn 1 mmol/ml

b.braun melsungen ag* - kalii chloridum - innrennslisþykkni, lausn - 1 mmol/ml